Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer

Francisco G. Pernas(National Cancer Institute), Zhong Chen(National Institutes of Health)

Clinical Cancer Research

March 24, 2009

10.1158/1078-0432.ccr-08-1011

Cited by 63

Related Papers

A signal network involving coactivated NF‐κB and STAT3 and altered p53 modulates BAX/BCL‐XL expression and promotes cell survival of head and neck squamous cell carcinomas

|International Journal of Cancer|2008|107

Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas

|Scientific Reports|2021|4

Supplementary Data from A Novel Nuclear Factor-κB Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status

|Unknown|2023|0